CTNM
Contineum Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.79
+1.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 51.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.57x
- Price / sales
- —
- Price / cash flow
- -7.41x
Enterprise value
- Enterprise value
- $146.2M
- EV / sales
- —
- EV / EBITDA
- -2.03x
- EV / EBIT
- -2.02x
- Market cap
- $384.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026